雑誌文献を検索します。書籍を検索する際には「書籍検索」を選択してください。

検索

書誌情報 詳細検索 by 医中誌

Japanese

Early phaseⅡ evaluation of anti-TNF-alpha antibody for Behçet disease Satoshi Nakamura 1,7 , Sadao Hori 2 , Machiko Shimakawa 2 , Manabu Mochizuki 3 , Sunao Sugita 3 , Hidetoshi Kawashima 4 , Satoki Ueno 5 , Shigeaki Ohno 6 1Dept of Ophthalmol,Yokohama City Univ Sch of Med 2Dept of Ophthalmol,Tokyo Women's Med Univ 3Dept of Ophthalmol and Vis Sci,Grad Sch,Tokyo Med and Dent Univ 4Dept of Ophthalmol,Univ of Tokyo Sch of Med 5Dept of Ophthalmol,St Marianna Univ Sch of Med 6Dept of Ophthalmol and Vis Sci,Hokkaido Univ Grad Sch of Med 7Yoshinocho Eye Clin pp.1685-1689
Published Date 2005/10/15
DOI https://doi.org/10.11477/mf.1410100165
  • Abstract
  • Look Inside

Purpose:To report the outcome of early phase-Ⅱ evaluation of infliximab,an anti-TNF-alpha antibody,for Behcet disease. Cases and Method:Thirteen patients of Behçet disease joined this multi-institutional study. All the cases had attacks of uveitis that failed to respond to immunosuppressive agents. Each patient received 4 sessions of intravenous infliximab during a 10-week period. The dosis was set either at 5 mg or 10 mg/kg at each session. Results:The frequency of ocular attacks decreased significantly. The visual acuity significantly improved. Diarrhea and nausea appeared as major side effects. Infection or autoantibody developed in some patients. Conclusion:Intravenous infliximab may be effective for uveitis in Behçet disease.


Copyright © 2005, Igaku-Shoin Ltd. All rights reserved.

基本情報

電子版ISSN 1882-1308 印刷版ISSN 0370-5579 医学書院

関連文献

もっと見る

文献を共有